Yngve Falck–Ytter

98.1k total citations · 27 hit papers
168 papers, 55.2k citations indexed

About

Yngve Falck–Ytter is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Hepatology. According to data from OpenAlex, Yngve Falck–Ytter has authored 168 papers receiving a total of 55.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 39 papers in Public Health, Environmental and Occupational Health and 37 papers in Hepatology. Recurrent topics in Yngve Falck–Ytter's work include Clinical practice guidelines implementation (30 papers), Liver Disease Diagnosis and Treatment (30 papers) and Hepatitis C virus research (28 papers). Yngve Falck–Ytter is often cited by papers focused on Clinical practice guidelines implementation (30 papers), Liver Disease Diagnosis and Treatment (30 papers) and Hepatitis C virus research (28 papers). Yngve Falck–Ytter collaborates with scholars based in United States, Canada and Norway. Yngve Falck–Ytter's co-authors include Regina Kunz, Andrew D Oxman, Gunn Elisabeth Vist, Gordon Guyatt, Holger J. Schünemann, Pablo Alonso‐Coello, Jan Brożek, Susan L. Norris, Elie A. Akl and Paul Glasziou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Yngve Falck–Ytter

157 papers receiving 54.0k citations

Hit Papers

GRADE: an emerging consensus on rating quality of evidenc... 2001 2026 2009 2017 2008 2011 2011 2008 2011 4.0k 8.0k 12.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
    2008 14.7k citations Gordon Guyatt, Andrew D Oxman et al. profile →
  2. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
    2011 7.2k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  3. GRADE guidelines: 3. Rating the quality of evidence
    2011 5.8k citations Andrew D Oxman, Regina Kunz et al. Journal of Clinical Epidemiology profile →
  4. What is “quality of evidence” and why is it important to clinicians?
    2008 2.3k citations Gordon Guyatt, Andrew D Oxman et al. profile →
  5. GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
    2011 2.1k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  6. GRADE guidelines 6. Rating the quality of evidence—imprecision
    2011 1.9k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  7. GRADE guidelines: 7. Rating the quality of evidence—inconsistency
    2011 1.7k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  8. Prevention of VTE in Orthopedic Surgery Patients
    2012 1.4k citations Yngve Falck–Ytter et al. profile →
  9. GRADE guidelines: 5. Rating the quality of evidence—publication bias
    2011 1.4k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  10. GRADE guidelines: 8. Rating the quality of evidence—indirectness
    2011 1.4k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  11. GRADE guidelines: 2. Framing the question and deciding on important outcomes
    2010 1.3k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  12. Going from evidence to recommendations
    2008 1.2k citations Gordon Guyatt, Andrew D Oxman et al. profile →
  13. GRADE guidelines: 9. Rating up the quality of evidence
    2011 971 citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  14. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
    2013 883 citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  15. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
    2012 785 citations Bryce D. Smith, Rebecca L. Morgan et al. PubMed profile →
  16. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
    2020 741 citations Adarsh Bhimraj, Rebecca L. Morgan et al. Clinical Infectious Diseases profile →
  17. American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
    2014 651 citations Joseph K. Lim, Yngve Falck–Ytter et al. Gastroenterology profile →
  18. Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
    2013 602 citations Rebecca L. Morgan, Brittney Baack et al. Annals of Internal Medicine profile →
  19. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes
    2012 563 citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  20. Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
    2001 522 citations Yngve Falck–Ytter et al. profile →
  21. American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
    2017 411 citations Geoffrey C. Nguyen, Yngve Falck–Ytter et al. Gastroenterology profile →
  22. American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
    2014 373 citations Yngve Falck–Ytter et al. Gastroenterology profile →
  23. AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders
    2020 261 citations Grace L. Su, Cynthia W. Ko et al. Gastroenterology profile →
  24. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia
    2019 189 citations Perica Davitkov, Shahnaz Sultan et al. Gastroenterology profile →
  25. AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma
    2022 131 citations Grace L. Su, Shahnaz Sultan et al. Gastroenterology profile →
  26. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline
    2024 40 citations Yngve Falck–Ytter et al. profile →
  27. AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals
    2025 15 citations Faisal S. Ali, Rubén Hernáez et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yngve Falck–Ytter United States 57 11.7k 10.9k 7.5k 6.4k 5.1k 168 55.2k
Patrick M. Bossuyt Netherlands 116 13.6k 1.2× 8.6k 0.8× 7.9k 1.0× 9.5k 1.5× 3.7k 0.7× 757 61.9k
Christopher H. Schmid United States 88 10.1k 0.9× 8.3k 0.8× 5.2k 0.7× 7.3k 1.2× 10.4k 2.0× 404 63.2k
Jonathan A C Sterne United Kingdom 97 13.3k 1.1× 12.0k 1.1× 9.2k 1.2× 8.7k 1.4× 7.6k 1.5× 402 84.3k
Regina Kunz Switzerland 44 11.0k 0.9× 6.8k 0.6× 8.6k 1.1× 6.1k 1.0× 5.9k 1.2× 118 54.1k
Henrik Toft Sørensen Denmark 119 16.9k 1.5× 14.3k 1.3× 9.4k 1.3× 9.5k 1.5× 13.4k 2.6× 1.6k 77.7k
Gunn Elisabeth Vist Norway 46 10.5k 0.9× 6.6k 0.6× 8.6k 1.1× 5.9k 0.9× 4.4k 0.9× 104 52.2k
Eric Vittinghoff United States 113 6.3k 0.5× 10.4k 1.0× 5.6k 0.7× 4.9k 0.8× 7.4k 1.4× 759 50.0k
Jonathan J Deeks United Kingdom 92 20.0k 1.7× 16.8k 1.5× 9.1k 1.2× 11.8k 1.9× 9.1k 1.8× 368 96.6k
John B. Wong United States 89 6.8k 0.6× 10.2k 0.9× 3.7k 0.5× 3.5k 0.5× 2.8k 0.5× 377 36.2k
Johannes B. Reitsma Netherlands 98 14.7k 1.3× 11.2k 1.0× 4.3k 0.6× 10.6k 1.7× 7.2k 1.4× 432 58.6k

Countries citing papers authored by Yngve Falck–Ytter

Since Specialization
Citations

This map shows the geographic impact of Yngve Falck–Ytter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yngve Falck–Ytter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yngve Falck–Ytter more than expected).

Fields of papers citing papers by Yngve Falck–Ytter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yngve Falck–Ytter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yngve Falck–Ytter. The network helps show where Yngve Falck–Ytter may publish in the future.

Co-authorship network of co-authors of Yngve Falck–Ytter

This figure shows the co-authorship network connecting the top 25 collaborators of Yngve Falck–Ytter. A scholar is included among the top collaborators of Yngve Falck–Ytter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yngve Falck–Ytter. Yngve Falck–Ytter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ali, Faisal S., Yngve Falck–Ytter, Reem A. Mustafa, et al.. (2025). Certainty of evidence assessment in high‐impact medical journals: A meta‐epidemiological survey. PubMed. 3(2). e70014–e70014.
2.
Ali, Faisal S., Rubén Hernáez, Daniel Q. Huang, et al.. (2025). AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals. Gastroenterology. 168(2). 267–284. 15 indexed citations breakdown →
3.
Murad, M. Hassan, Rebecca L. Morgan, Yngve Falck–Ytter, et al.. (2025). Risk of bias assessment tools often addressed items not related to risk of bias and used numerical scores. Journal of Clinical Epidemiology. 180. 111684–111684. 1 indexed citations
4.
Bauer, Seth R., Patrick M. Wieruszewski, Siddharth Dugar, et al.. (2025). ADJUNCTIVE VASOPRESSORS AND SHORT-TERM MORTALITY IN ADULTS WITH SEPTIC SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS. Shock. 63(5). 668–676. 1 indexed citations
5.
Balduzzi, Alberto, Francesco Maria Carrano, Yngve Falck–Ytter, et al.. (2025). What Constitutes a High‐Quality Guideline: Exploring Consumers' Views. United European Gastroenterology Journal. 13(2). 268–275.
6.
Hayden, Mary K., Kimberly E. Hanson, Janet A. Englund, et al.. (2024). Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019: Serologic Testing. Clinical Infectious Diseases. 13 indexed citations
7.
Áinle, Fionnuala Ní, Donna DiMichele, Yngve Falck–Ytter, et al.. (2024). ISTH clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology: considerations for practice management and implementation. Journal of Thrombosis and Haemostasis. 22(9). 2404–2409. 2 indexed citations
8.
Stratton, Matthew T., Zeinab Hosseini, Yngve Falck–Ytter, et al.. (2023). Certainty of Evidence Assessment in Systematic Reviews Published by High-Impact Sports Science Journals: A Meta-epidemiological Study. Sports Medicine. 54(2). 473–484. 2 indexed citations
9.
Su, Grace L., Cynthia W. Ko, Přemysl Berčík, et al.. (2020). AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology. 159(2). 697–705. 261 indexed citations breakdown →
10.
Dobler, Claudia C., Rebecca L. Morgan, Yngve Falck–Ytter, Víctor M. Montori, & M. Hassan Murad. (2018). Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment. BMJ evidence-based medicine. 23(2). 50–53. 5 indexed citations
11.
Herrine, Steven K., Paul Moayyedi, Robert S. Brown, & Yngve Falck–Ytter. (2017). American Gastroenterological Association Institute Technical Review on Initial Testing and Management of Acute Liver Disease. Gastroenterology. 152(3). 648–664.e5. 10 indexed citations
12.
Nguyen, Geoffrey C., Edward V. Loftus, Ikuo Hirano, et al.. (2016). American Gastroenterological Association Institute Guideline on the Management of Crohn’s Disease After Surgical Resection. Gastroenterology. 152(1). 271–275. 173 indexed citations
13.
Patel, Mayur B., Daniel C. Cullinane, Matthew Day, et al.. (2015). Cervical spine collar clearance in the obtunded adult blunt trauma patient. The Journal of Trauma: Injury, Infection, and Critical Care. 78(2). 430–441. 77 indexed citations
14.
Seamon, Mark J., Elliott R. Haut, Kyle J. Van Arendonk, et al.. (2015). An evidence-based approach to patient selection for emergency department thoracotomy. The Journal of Trauma: Injury, Infection, and Critical Care. 79(1). 159–173. 203 indexed citations
15.
Morgan, Rebecca L., Brittney Baack, Bryce D. Smith, et al.. (2013). Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma. Annals of Internal Medicine. 7 indexed citations
16.
Hardy, Gareth, Nicole L. Yonkers, Amy Hirsch, et al.. (2012). Genetically Associated CD16+56− Natural Killer Cell Interferon (IFN)–αR Expression Regulates Signaling and Is Implicated in IFN-α–Induced Hepatitis C Virus Decline. The Journal of Infectious Diseases. 205(7). 1131–1141. 8 indexed citations
17.
Guyatt, Gordon, Andrew D Oxman, Elie A. Akl, et al.. (2011). GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology. 64(4). 383–394. 7216 indexed citations breakdown →
18.
Ho, Samuel B., Eric Dieperink, Shanglei Liu, et al.. (2011). U.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients. Digestive Diseases and Sciences. 56(3). 880–888. 5 indexed citations
19.
Guyatt, Gordon, et al.. (2009). GRADE: going from evidence to recommendations. Zhongguo xunzheng yixue zazhi. 20 indexed citations
20.
Das, Ananya, et al.. (2007). Ultrathin Esophagoscopy in Screening for Barrett's Esophagus at a Veterans Administration Hospital: Easy Access Does Not Lead to Referrals. The American Journal of Gastroenterology. 103(1). 92–97. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick M. Bossuyt Breakdown of academic impact, for papers by Christopher H. Schmid Breakdown of academic impact, for papers by Jonathan A C Sterne Breakdown of academic impact, for papers by Regina Kunz Breakdown of academic impact, for papers by Henrik Toft Sørensen Breakdown of academic impact, for papers by Gunn Elisabeth Vist Breakdown of academic impact, for papers by Eric Vittinghoff Breakdown of academic impact, for papers by Jonathan J Deeks Breakdown of academic impact, for papers by John B. Wong Breakdown of academic impact, for papers by Johannes B. Reitsma
Rankless by CCL
2026